Porton Pharma Solutions Ltd. (SHE:300363)
China
· Delayed Price · Currency is CNY 21.28
-0.60 (-2.74%)
Apr 29, 2026, 3:06 PM CST
Porton Pharma Solutions Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 11,538 | 12,553 | 8,602 | 13,735 | 22,305 | 48,697 | Upgrade
|
| Market Cap Growth | 14.41% | 45.93% | -37.37% | -38.42% | -54.20% | 145.68% | Upgrade
|
| Enterprise Value | 11,271 | 13,106 | 9,403 | 13,249 | 20,598 | 48,168 | Upgrade
|
| Last Close Price | 21.28 | 23.24 | 15.77 | 24.34 | 38.24 | 83.52 | Upgrade
|
| PE Ratio | 93.98 | 130.30 | - | 51.47 | 11.12 | 92.95 | Upgrade
|
| Forward PE | 57.51 | 68.76 | 54.14 | 27.07 | 12.63 | 71.85 | Upgrade
|
| PS Ratio | 3.29 | 3.67 | 2.86 | 3.75 | 3.17 | 15.68 | Upgrade
|
| PB Ratio | 2.10 | 2.28 | 1.59 | 2.25 | 3.45 | 11.63 | Upgrade
|
| P/TBV Ratio | 2.39 | 2.61 | 1.85 | 2.62 | 4.13 | 13.64 | Upgrade
|
| P/FCF Ratio | 24.44 | 27.03 | - | - | 16.03 | - | Upgrade
|
| P/OCF Ratio | 17.12 | 16.58 | 21.21 | 21.83 | 8.70 | 101.42 | Upgrade
|
| PEG Ratio | - | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 | Upgrade
|
| EV/Sales Ratio | 3.22 | 3.83 | 3.12 | 3.61 | 2.93 | 15.51 | Upgrade
|
| EV/EBITDA Ratio | 19.13 | 27.29 | 92.37 | 22.82 | 8.40 | 66.91 | Upgrade
|
| EV/EBIT Ratio | 69.03 | 102.31 | - | 45.39 | 9.29 | 86.65 | Upgrade
|
| EV/FCF Ratio | 23.87 | 28.22 | - | - | 14.81 | - | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.28 | 0.36 | 0.32 | 0.14 | 0.18 | Upgrade
|
| Debt / EBITDA Ratio | 1.63 | 2.76 | 11.02 | 3.08 | 0.37 | 0.99 | Upgrade
|
| Debt / FCF Ratio | 2.02 | 3.25 | - | - | 0.66 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.07 | 0.02 | 0.09 | 0.00 | -0.30 | -0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.76 | 0.21 | 4.73 | 0.01 | -0.79 | -0.66 | Upgrade
|
| Net Debt / FCF Ratio | -0.83 | 0.22 | -5.66 | -0.01 | -1.38 | 1.60 | Upgrade
|
| Asset Turnover | 0.41 | 0.39 | 0.33 | 0.38 | 0.84 | 0.56 | Upgrade
|
| Inventory Turnover | 3.23 | 3.15 | 3.10 | 2.76 | 4.10 | 3.11 | Upgrade
|
| Quick Ratio | 1.27 | 1.25 | 1.37 | 1.94 | 1.47 | 1.12 | Upgrade
|
| Current Ratio | 1.85 | 1.82 | 1.90 | 2.63 | 1.81 | 1.52 | Upgrade
|
| Return on Equity (ROE) | 1.14% | 0.56% | -6.36% | 2.79% | 36.34% | 12.55% | Upgrade
|
| Return on Assets (ROA) | 1.15% | 0.92% | -1.54% | 1.87% | 16.59% | 6.28% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.71% | 0.82% | -3.73% | 3.90% | 46.32% | 15.82% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.40% | 1.90% | -3.20% | 3.70% | 31.10% | 12.50% | Upgrade
|
| Earnings Yield | 1.11% | 0.77% | -3.35% | 1.94% | 8.99% | 1.08% | Upgrade
|
| FCF Yield | 4.09% | 3.70% | -0.99% | -3.65% | 6.24% | -0.61% | Upgrade
|
| Dividend Yield | 0.41% | 0.39% | - | 2.00% | 2.89% | 0.23% | Upgrade
|
| Payout Ratio | 21.14% | 31.25% | - | 234.79% | 6.44% | 15.80% | Upgrade
|
| Buyback Yield / Dilution | -11.15% | 1.42% | 0.31% | -0.21% | -0.62% | 0.11% | Upgrade
|
| Total Shareholder Return | -10.73% | 1.81% | 0.31% | 1.79% | 2.27% | 0.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.